Regula’s top-selling video spectral comparator has undergone a major redesign to meet the growing complexity of modern-day ...

Regula is upgrading its popular video spectral comparator, the 4306M, to keep pace with the complexities of document ...

While the approval is a historic event for the BiTE drug class in solid tumours, the market share opportunity is restricted ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...

Rigorous answers about the program’s effects on drug innovation are still a ways off. However, some information about ...

Johnson & Johnson (JNJ) posts Phase 3 trial win for Akkega plus prednisone in metastatic castration-sensitive prostate cancer ...

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

U.S. INDICATIONS AND USAGE POMBILITI in combination with OPFOLDA is indicated for the treatment of adult patients with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency) ...

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer ...

The summer of 2025 will make football history. From June 14 to July 13, the United States will host the first expanded ...